{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:46:06Z","timestamp":1786995966024,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.prp.2014.06.009","type":"journal-article","created":{"date-parts":[[2014,6,23]],"date-time":"2014-06-23T20:46:55Z","timestamp":1403556415000},"page":"1054-1063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis"],"prefix":"10.1016","volume":"210","author":[{"given":"Anji","family":"Anura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-3425","authenticated-orcid":false,"given":"Raunak Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousumi","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan Rashmi","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajoy Kumar","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmoy","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2014.06.009_bib0005","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/jid.2008.102","article-title":"E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents","volume":"128","author":"Alt-Holland","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2014.06.009_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2559.2011.03929.x","article-title":"Nuclear translocation of \u03b2-catenin synchronized with loss of E-cadherin in oral epithelial dysplasia with a characteristic two-phase appearance","volume":"59","author":"Alvarado","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2014.06.009_bib0015","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1158\/1078-0432.CCR-04-0572","article-title":"Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis","volume":"11","author":"Arora","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2014.06.009_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cdip.2005.10.008","article-title":"Epithelial dysplasia of the oral mucosa\u2014diagnostic problems and prognostic features","volume":"12","author":"Bouquot","year":"2006","journal-title":"Curr. Diagn. Pathol."},{"issue":"Suppl.","key":"10.1016\/j.prp.2014.06.009_bib0025","first-page":"S19.e11","article-title":"Management of oral epithelial dysplasia: a review","volume":"103","author":"Brennan","year":"2007","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.prp.2014.06.009_bib0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1242\/jcs.100115","article-title":"E-cadherin-integrin crosstalk in cancer invasion and metastasis","volume":"126","author":"Canel","year":"2013","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.prp.2014.06.009_bib0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nature06953","article-title":"A two-tiered mechanism for stabilization and immobilization of E-cadherin","volume":"453","author":"Cavey","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.prp.2014.06.009_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0929-6646(11)60008-9","article-title":"Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan","volume":"110","author":"Cheng","year":"2011","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.prp.2014.06.009_bib0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yexmp.2013.08.006","article-title":"Epithelio-mesenchymal transitional attributes in oral sub-mucous fibrosis","volume":"95","author":"Das","year":"2013","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.prp.2014.06.009_bib0050","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/jcp.2010.078964","article-title":"Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression","volume":"63","author":"Das","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2014.06.009_bib0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.oraloncology.2005.07.010","article-title":"Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma","volume":"42","author":"Diniz-Freitas","year":"2006","journal-title":"Oral Oncol."},{"key":"10.1016\/j.prp.2014.06.009_bib0065","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1038\/sj.onc.1206813","article-title":"Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels","volume":"22","author":"Fonsatti","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2014.06.009_bib0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1479-5876-2-18","article-title":"Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer","volume":"2","author":"Fonsatti","year":"2004","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2014.06.009_bib0075","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.tripleo.2010.11.018","article-title":"Increased subepithelial vascularization and VEGF expression reveal potentially malignant changes in human oral mucosa lesions","volume":"111","author":"Gandolfo","year":"2011","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.prp.2014.06.009_bib0080","first-page":"39","article-title":"Oral submucous fibrosis \u2013 current concepts in etiopathogenesis","volume":"1","author":"Gupta","year":"2008","journal-title":"People J. Sci. Res."},{"key":"10.1016\/j.prp.2014.06.009_bib0085","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4161\/cc.7.9.5804","article-title":"Hypoxia-inducible factor signaling in the development of tissue fibrosis","volume":"7","author":"Higgins","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.prp.2014.06.009_bib0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.prp.2014.06.009_bib0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijom.2006.09.017","article-title":"Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma","volume":"36","author":"Johnstone","year":"2007","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.prp.2014.06.009_bib0100","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial\u2013mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2014.06.009_bib0105","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"Kamangar","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2014.06.009_bib0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0973-1482.98970","article-title":"Pathogenesis of oral submucous fibrosis","volume":"8","author":"Khan","year":"2012","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.prp.2014.06.009_bib0115","series-title":"Endocrine Pathology","first-page":"1","article-title":"Methods in cellular and molecular pathology","author":"Komminoth","year":"2010"},{"key":"10.1016\/j.prp.2014.06.009_bib0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.otohns.2005.08.026","article-title":"Decreased E-cadherin but not \u03b2-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas","volume":"134","author":"Kurtz","year":"2006","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.prp.2014.06.009_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2014.06.009_bib0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijom.2004.10.016","article-title":"Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas","volume":"34","author":"Li","year":"2005","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.prp.2014.06.009_bib0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ncb2024","article-title":"miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis","volume":"12","author":"Ma","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.prp.2014.06.009_bib0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10238-010-0095-4","article-title":"VEGF expression and angiogenesis in oral squamous cell carcinoma: an immunohistochemical and morphometric study","volume":"10","author":"M\u0103rg\u0103ritescu","year":"2010","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.prp.2014.06.009_bib0145","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-04-3399","article-title":"E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs","volume":"65","author":"Margulis","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2014.06.009_bib0150","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/sj.bjc.6604733","article-title":"Angiogenesis in pre-malignant conditions","volume":"99","author":"Menakuru","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2014.06.009_bib0155","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0528.1985.tb00468.x","article-title":"Malignant transformation rate in oral submucous fibrosis over a 17-year period","volume":"13","author":"Murti","year":"1985","journal-title":"Community Dent. Oral Epidemiol."},{"key":"10.1016\/j.prp.2014.06.009_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0714.2007.00579.x","article-title":"Natural history of potentially malignant oral lesions and conditions: an overview of the literature","volume":"37","author":"Napier","year":"2008","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.prp.2014.06.009_bib0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.oraloncology.2011.10.003","article-title":"VEGF-A immunohistochemical and mRNA expression in tissues and its serum levels in potentially malignant oral lesions and oral squamous cell carcinomas","volume":"48","author":"Nayak","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.prp.2014.06.009_bib0170","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.1073\/pnas.1101321108","article-title":"VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting","volume":"108","author":"Oladipupo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2014.06.009_bib0175","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways","volume":"68","author":"Onder","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2014.06.009_bib0180","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1128\/MCB.25.1.389-402.2005","article-title":"Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell\u2013cell adhesion during epithelial to mesenchymal transitions","volume":"25","author":"Palacios","year":"2005","journal-title":"Cell Mol. Biol."},{"key":"10.1016\/j.prp.2014.06.009_bib0185","first-page":"603","article-title":"Oral submucous fibrosis: a review","volume":"18","author":"Pindborg","year":"1989","journal-title":"Ann. Acad. Med. Singap."},{"key":"10.1016\/j.prp.2014.06.009_bib0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.cellbio.22.010305.104241","article-title":"Structure and mechanism of cadherins and catenins in cell\u2013cell contacts","volume":"23","author":"Pokutta","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2014.06.009_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1535-7163.MCT-09-0321","article-title":"Multifactorial regulation of E-cadherin expression: an integrative study","volume":"9","author":"Reinhold","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prp.2014.06.009_bib0200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2007.01.006","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumor progression","volume":"62","author":"Roskoski","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.prp.2014.06.009_bib0205","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/sj.bjc.6690530","article-title":"Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer","volume":"80","author":"Sato","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2014.06.009_bib0210","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003053","article-title":"Structure and biochemistry of cadherins and catenins","volume":"1","author":"Shapiro","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.prp.2014.06.009_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1368-8375(03)00127-1","article-title":"Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma","volume":"40","author":"Shintani","year":"2004","journal-title":"Oral Oncol."},{"key":"10.1016\/j.prp.2014.06.009_bib0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12105-007-0014-5","article-title":"Update on oral epithelial dysplasia and progression to cancer","volume":"1","author":"Speight","year":"2007","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.prp.2014.06.009_bib0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oxfordjournals.jncimonographs.a003443","article-title":"Biology of oral mucosa and esophagus","volume":"2001","author":"Squier","year":"2001","journal-title":"JNCI Monogr."},{"key":"10.1016\/j.prp.2014.06.009_bib0230","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0714.2007.00625.x","article-title":"Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis","volume":"37","author":"Tilakaratne","year":"2008","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.prp.2014.06.009_bib0235","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.oraloncology.2005.08.005","article-title":"Oral submucous fibrosis: review on aetiology and pathogenesis","volume":"42","author":"Tilakaratne","year":"2006","journal-title":"Oral Oncol."},{"key":"10.1016\/j.prp.2014.06.009_bib0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.prp.2014.06.009_bib0245","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1600-0714.2007.00582.x","article-title":"Nomenclature and classification of potentially malignant disorders of the oral mucosa","volume":"36","author":"Warnakulasuriya","year":"2007","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.prp.2014.06.009_bib0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0714.2007.00584.x","article-title":"Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement","volume":"37","author":"Warnakulasuriya","year":"2008","journal-title":"J. Oral Pathol. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033814001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033814001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T17:09:29Z","timestamp":1565543369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033814001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0344033814001794"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2014.06.009","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2014.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}